These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

761 related articles for article (PubMed ID: 21068237)

  • 21. Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms.
    Adedeji AO; Severson W; Jonsson C; Singh K; Weiss SR; Sarafianos SG
    J Virol; 2013 Jul; 87(14):8017-28. PubMed ID: 23678171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Transmembrane Protease Serine 2 (TMPRSS2) Non-Protease Domains Regulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike-Mediated Virus Entry.
    Strobelt R; Adler J; Shaul Y
    Viruses; 2023 Oct; 15(10):. PubMed ID: 37896901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor.
    Ge XY; Li JL; Yang XL; Chmura AA; Zhu G; Epstein JH; Mazet JK; Hu B; Zhang W; Peng C; Zhang YJ; Luo CM; Tan B; Wang N; Zhu Y; Crameri G; Zhang SY; Wang LF; Daszak P; Shi ZL
    Nature; 2013 Nov; 503(7477):535-8. PubMed ID: 24172901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin.
    Ouyang Y; Bagalkot T; Fitzgerald W; Sadovsky E; Chu T; Martínez-Marchal A; Brieño-Enríquez M; Su EJ; Margolis L; Sorkin A; Sadovsky Y
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33853873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolutionary Arms Race between Virus and Host Drives Genetic Diversity in Bat Severe Acute Respiratory Syndrome-Related Coronavirus Spike Genes.
    Guo H; Hu BJ; Yang XL; Zeng LP; Li B; Ouyang S; Shi ZL
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32699095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems.
    Zhang F; Li W; Feng J; Ramos da Silva S; Ju E; Zhang H; Chang Y; Moore PS; Guo H; Gao SJ
    J Med Virol; 2021 Dec; 93(12):6671-6685. PubMed ID: 34324210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonmuscle myosin heavy chain IIA facilitates SARS-CoV-2 infection in human pulmonary cells.
    Chen J; Fan J; Chen Z; Zhang M; Peng H; Liu J; Ding L; Liu M; Zhao C; Zhao P; Zhang S; Zhang X; Xu J
    Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34873039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus.
    Kuhn JH; Li W; Choe H; Farzan M
    Cell Mol Life Sci; 2004 Nov; 61(21):2738-43. PubMed ID: 15549175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.
    Letko M; Marzi A; Munster V
    Nat Microbiol; 2020 Apr; 5(4):562-569. PubMed ID: 32094589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus.
    Cocozza F; Névo N; Piovesana E; Lahaye X; Buchrieser J; Schwartz O; Manel N; Tkach M; Théry C; Martin-Jaular L
    J Extracell Vesicles; 2020 Dec; 10(2):e12050. PubMed ID: 33391636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated FiO
    Myti D; Gunjak M; Casado F; Khaghani Raziabad S; Nardiello C; Vadász I; Herold S; Pryhuber G; Seeger W; Morty RE
    Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L670-L674. PubMed ID: 32878480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response.
    Glowacka I; Bertram S; Müller MA; Allen P; Soilleux E; Pfefferle S; Steffen I; Tsegaye TS; He Y; Gnirss K; Niemeyer D; Schneider H; Drosten C; Pöhlmann S
    J Virol; 2011 May; 85(9):4122-34. PubMed ID: 21325420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhesus angiotensin converting enzyme 2 supports entry of severe acute respiratory syndrome coronavirus in Chinese macaques.
    Chen Y; Liu L; Wei Q; Zhu H; Jiang H; Tu X; Qin C; Chen Z
    Virology; 2008 Nov; 381(1):89-97. PubMed ID: 18801550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.
    Roehrich H; Yuan C; Hou JH
    Cornea; 2020 Dec; 39(12):1556-1562. PubMed ID: 32826650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2.
    Song W; Gui M; Wang X; Xiang Y
    PLoS Pathog; 2018 Aug; 14(8):e1007236. PubMed ID: 30102747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2.
    Wang S; Guo F; Liu K; Wang H; Rao S; Yang P; Jiang C
    Virus Res; 2008 Sep; 136(1-2):8-15. PubMed ID: 18554741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity.
    Sakaguchi W; Kubota N; Shimizu T; Saruta J; Fuchida S; Kawata A; Yamamoto Y; Sugimoto M; Yakeishi M; Tsukinoki K
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2.
    Moore MJ; Dorfman T; Li W; Wong SK; Li Y; Kuhn JH; Coderre J; Vasilieva N; Han Z; Greenough TC; Farzan M; Choe H
    J Virol; 2004 Oct; 78(19):10628-35. PubMed ID: 15367630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds.
    Haga S; Nagata N; Okamura T; Yamamoto N; Sata T; Yamamoto N; Sasazuki T; Ishizaka Y
    Antiviral Res; 2010 Mar; 85(3):551-5. PubMed ID: 19995578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.